ArticleTranslational cancer research2026
Association of primary lesion surgery and surgical modality with overall survival in patients with stage IV cutaneous melanoma: a population-based study.
Article in Translational cancer research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Evidence regarding the impact of primary lesion surgery on survival in stage IV cutaneous melanoma (CM) patients is scarce. This study investigated the prognostic value of primary lesion resection for stage IV CM and survival differences across various surgical modalities. Methods: We extracted data on stage IV (M1a-c) CM patients diagnosed between 2010 and 2015 from the Surveillance, Epidemiology, and End Results (SEER) database. The cohort was divided into a surgical group (primary lesion resection) and a non-surgical control group, with overall survival (OS) as the primary endpoint. Propensity score matching (PSM) and Kaplan-Meier analysis were applied to compare clinical outcomes and identify relevant prognostic factors. Results: A total of 3,155 patients were included. After 1:2 PSM, 648 and 1,228 patients were assigned to the surgical and non-surgical groups, respectively. Patients who underwent primary lesion surgery had significantly longer OS than non-surgical patients both before and after PSM (all P<0.001). Subgroup analysis showed that gross excision or wide excision was associated with markedly longer OS than local tumor resection (P<0.001 and P=0.002, respectively). Gross excision had a numerically longer median OS than wide excision (25 Conclusions: Primary lesion surgery significantly improves OS in stage IV CM patients, and surgical modality correlates with survival outcomes. Gross excision may be the most effective approach, while wide excision may not provide additional survival benefits and may be unnecessary for this patient population in clinical practice.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.